Evidence for regulation of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat

S. Balasubramaniam, J. L. Goldstein, J. R. Faust, M. S. Brown

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The adenine analogue 4 aminopyrazolopyrimidine has been reported previously to reduce the hepatic secretion of plasma lipoproteins in rats, thereby lowering the plasma cholesterol level. In the current studies, reduction of the plasma cholesterol level by 90% in rats through the administration of aminopyrazolopyrimidine was found to be associated with a 5 to 30 fold increase in the activity of 3 hydroxy 3 methylglutaryl coenzyme A reductase [mevalonate: NADP+ oxidoreductase (CoA acylating), EC 1.1.1.34] in kidney and lung. In both tissues, the enhanced activity of this microsomal enzyme was associated with a 3 fold elevation in the rate of cholesterol synthesis from either [14C]acetate or [14C]octanoate. Comparable increases were not observed in the activities of several other microsomal enzymes or in the rates of [14C]acetate incorporation into saponifiable lipids or CO2. When administration of 4 aminopyrazolopyrimidine was terminated, plasma cholesterol levels rose and 3 hydroxy 3 methylglutaryl coenzyme A reductase activity declined in the kidney in a reciprocal manner. These data are consistent with the hypothesis that the low levels of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis that are normally observed in certain nonhepatic tissues of the rat are due to an active form of feedback regulation mediated by cholesterol carried in plasma lipoproteins.

Original languageEnglish (US)
Pages (from-to)2564-2568
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume73
Issue number8
StatePublished - 1976

Fingerprint

Cholesterol
Oxidoreductases
Lipoproteins
Acetates
Kidney
Mevalonic Acid
Adenine
Enzymes
Coenzyme A
NADP
cholesterol reductase
3-hydroxy-3-methylglutaryl-coenzyme A
Lipids
Lung
Liver

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

@article{590b31ba70ee4114a0bdb7a3b4baedea,
title = "Evidence for regulation of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat",
abstract = "The adenine analogue 4 aminopyrazolopyrimidine has been reported previously to reduce the hepatic secretion of plasma lipoproteins in rats, thereby lowering the plasma cholesterol level. In the current studies, reduction of the plasma cholesterol level by 90{\%} in rats through the administration of aminopyrazolopyrimidine was found to be associated with a 5 to 30 fold increase in the activity of 3 hydroxy 3 methylglutaryl coenzyme A reductase [mevalonate: NADP+ oxidoreductase (CoA acylating), EC 1.1.1.34] in kidney and lung. In both tissues, the enhanced activity of this microsomal enzyme was associated with a 3 fold elevation in the rate of cholesterol synthesis from either [14C]acetate or [14C]octanoate. Comparable increases were not observed in the activities of several other microsomal enzymes or in the rates of [14C]acetate incorporation into saponifiable lipids or CO2. When administration of 4 aminopyrazolopyrimidine was terminated, plasma cholesterol levels rose and 3 hydroxy 3 methylglutaryl coenzyme A reductase activity declined in the kidney in a reciprocal manner. These data are consistent with the hypothesis that the low levels of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis that are normally observed in certain nonhepatic tissues of the rat are due to an active form of feedback regulation mediated by cholesterol carried in plasma lipoproteins.",
author = "S. Balasubramaniam and Goldstein, {J. L.} and Faust, {J. R.} and Brown, {M. S.}",
year = "1976",
language = "English (US)",
volume = "73",
pages = "2564--2568",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Evidence for regulation of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat

AU - Balasubramaniam, S.

AU - Goldstein, J. L.

AU - Faust, J. R.

AU - Brown, M. S.

PY - 1976

Y1 - 1976

N2 - The adenine analogue 4 aminopyrazolopyrimidine has been reported previously to reduce the hepatic secretion of plasma lipoproteins in rats, thereby lowering the plasma cholesterol level. In the current studies, reduction of the plasma cholesterol level by 90% in rats through the administration of aminopyrazolopyrimidine was found to be associated with a 5 to 30 fold increase in the activity of 3 hydroxy 3 methylglutaryl coenzyme A reductase [mevalonate: NADP+ oxidoreductase (CoA acylating), EC 1.1.1.34] in kidney and lung. In both tissues, the enhanced activity of this microsomal enzyme was associated with a 3 fold elevation in the rate of cholesterol synthesis from either [14C]acetate or [14C]octanoate. Comparable increases were not observed in the activities of several other microsomal enzymes or in the rates of [14C]acetate incorporation into saponifiable lipids or CO2. When administration of 4 aminopyrazolopyrimidine was terminated, plasma cholesterol levels rose and 3 hydroxy 3 methylglutaryl coenzyme A reductase activity declined in the kidney in a reciprocal manner. These data are consistent with the hypothesis that the low levels of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis that are normally observed in certain nonhepatic tissues of the rat are due to an active form of feedback regulation mediated by cholesterol carried in plasma lipoproteins.

AB - The adenine analogue 4 aminopyrazolopyrimidine has been reported previously to reduce the hepatic secretion of plasma lipoproteins in rats, thereby lowering the plasma cholesterol level. In the current studies, reduction of the plasma cholesterol level by 90% in rats through the administration of aminopyrazolopyrimidine was found to be associated with a 5 to 30 fold increase in the activity of 3 hydroxy 3 methylglutaryl coenzyme A reductase [mevalonate: NADP+ oxidoreductase (CoA acylating), EC 1.1.1.34] in kidney and lung. In both tissues, the enhanced activity of this microsomal enzyme was associated with a 3 fold elevation in the rate of cholesterol synthesis from either [14C]acetate or [14C]octanoate. Comparable increases were not observed in the activities of several other microsomal enzymes or in the rates of [14C]acetate incorporation into saponifiable lipids or CO2. When administration of 4 aminopyrazolopyrimidine was terminated, plasma cholesterol levels rose and 3 hydroxy 3 methylglutaryl coenzyme A reductase activity declined in the kidney in a reciprocal manner. These data are consistent with the hypothesis that the low levels of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity and cholesterol synthesis that are normally observed in certain nonhepatic tissues of the rat are due to an active form of feedback regulation mediated by cholesterol carried in plasma lipoproteins.

UR - http://www.scopus.com/inward/record.url?scp=0017068820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017068820&partnerID=8YFLogxK

M3 - Article

C2 - 1066664

AN - SCOPUS:0017068820

VL - 73

SP - 2564

EP - 2568

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -